Advertisement

Ads Placeholder
Loading...

ALK-Abelló A/S

AKBLFPNK
Healthcare
Biotechnology
$31.35
$0.00(0.00%)
U.S. Market opens in 3h 35m

ALK-Abelló A/S (AKBLF) Stock Overview

Explore ALK-Abelló A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6.3B
P/E Ratio37.06
EPS (TTM)$0.83
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$35.17
3 Months$44.50
1 Year Target$43.73

AKBLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ALK-Abelló A/S (AKBLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 22.22, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $43.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 37.06 and a market capitalization of 6.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-5.94%
3-Month Change
-13.16%
6-Month Change
8.29%
Year-to-Date (YTD) Change
-13.16%
1-Year Change
20.81%
3-Year Change
123.93%
5-Year Change
64.14%
All-Time (Max) Change
569.87%

Contact Information

45 45 74 75 76
Boge Alle 6-8, Horsholm, NaN, 2970

Company Facts

27,360 Employees
IPO DateNov 16, 2009
CountryDK
Actively Trading

Frequently Asked Questions